An attempt to determine if pituitary responsiveness to GnRH (gonadotropin releasing hormone) is enhanced at low GnRH doses in healthy older men compared to young men. With aging, the amount of testosterone secreted by the testes diminishes. It is thought to play an important role in age associated disabilities such as loss of muscle mass, loss of muscle strength, decreased bone density, hip fracture, loss of sexual function, and diminished sense of well being. The issue is of enormous importance to the current veteran population, being overwhelmingly male, older, and with greater chance of falling due to muscle weakness. Breaks of osteoporotic bones can result in long-term nursing care. The first objective of this study is to test the hypothesis that age alters the sensitivity of the dose-responsive relationship between GnRH and LH (luteinizing hormone). The second objective is to test the hypothesis that the Leydig cells (clusters of cells that make up the endocrine tissue of the testes) of older men are less capable of secreting youthful quantities of testosterone when stimulated by doses of LH given to the subject at regular intervals. There will be 30 male subjects, of any race, for each of the parts of the randomized, controlled trial parts of the study. Ages will be between 20-40 and 60-80. All subjects will be entirely healthy men with no acute or chronic illnesses within four weeks before entering the study. Weight will be within 20% of ideal. The subjects will be recruited from the community through computerized search of elderly male veterans registered in two Veterans Affairs data banks at Richmond and Salem, Virginia, as well as advertisement in public venues. At the beginning of the study, subjects will receive an injection of the medication which will temporarily shut off the bodies natural production of stimulatory hormones. Three weeks later, there will be a 36 hour admission to the General Clinical Research Center. Injections will be given every two hours and blood will be drawn every ten minutes to measure the production of testosterone.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
2000
Total Cost
$648
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications